591 related articles for article (PubMed ID: 32201080)
21. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S
ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435
[TBL] [Abstract][Full Text] [Related]
22. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
Qiao B; Olvera de la Cruz M
ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
[TBL] [Abstract][Full Text] [Related]
23. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
24. COVID-19: Time to exonerate the pangolin from the transmission of SARS-CoV-2 to humans.
Frutos R; Serra-Cobo J; Chen T; Devaux CA
Infect Genet Evol; 2020 Oct; 84():104493. PubMed ID: 32768565
[TBL] [Abstract][Full Text] [Related]
25. Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2.
Basu A; Sarkar A; Maulik U
Sci Rep; 2020 Oct; 10(1):17699. PubMed ID: 33077836
[TBL] [Abstract][Full Text] [Related]
26. Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection.
Wang J; Xu X; Zhou X; Chen P; Liang H; Li X; Zhong W; Hao P
J Gen Virol; 2020 Sep; 101(9):921-924. PubMed ID: 32538738
[TBL] [Abstract][Full Text] [Related]
27. Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor.
Zhao P; Praissman JL; Grant OC; Cai Y; Xiao T; Rosenbalm KE; Aoki K; Kellman BP; Bridger R; Barouch DH; Brindley MA; Lewis NE; Tiemeyer M; Chen B; Woods RJ; Wells L
Cell Host Microbe; 2020 Oct; 28(4):586-601.e6. PubMed ID: 32841605
[TBL] [Abstract][Full Text] [Related]
28. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein.
Behloul N; Baha S; Shi R; Meng J
Virus Res; 2020 Sep; 286():198058. PubMed ID: 32531235
[TBL] [Abstract][Full Text] [Related]
29. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19.
Zhang S; Liu Y; Wang X; Yang L; Li H; Wang Y; Liu M; Zhao X; Xie Y; Yang Y; Zhang S; Fan Z; Dong J; Yuan Z; Ding Z; Zhang Y; Hu L
J Hematol Oncol; 2020 Sep; 13(1):120. PubMed ID: 32887634
[TBL] [Abstract][Full Text] [Related]
31. Effect of Early pregnancy associated protein-1 on Spike protein and ACE2 interactions: Implications in SARS Cov-2 vertical transmission.
Voina VC; Swain S; Kammili N; Mahalakshmi G; Muttineni R; Chander Bingi T; Kondapi AK
Placenta; 2024 Jul; 152():39-52. PubMed ID: 38788480
[TBL] [Abstract][Full Text] [Related]
32. The Discovery of a Putative Allosteric Site in the SARS-CoV-2 Spike Protein Using an Integrated Structural/Dynamic Approach.
Di Paola L; Hadi-Alijanvand H; Song X; Hu G; Giuliani A
J Proteome Res; 2020 Nov; 19(11):4576-4586. PubMed ID: 32551648
[TBL] [Abstract][Full Text] [Related]
33. COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2.
Mittal A; Manjunath K; Ranjan RK; Kaushik S; Kumar S; Verma V
PLoS Pathog; 2020 Aug; 16(8):e1008762. PubMed ID: 32822426
[TBL] [Abstract][Full Text] [Related]
34. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.
Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P
Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769
[TBL] [Abstract][Full Text] [Related]
35. Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism.
Othman H; Bouslama Z; Brandenburg JT; da Rocha J; Hamdi Y; Ghedira K; Srairi-Abid N; Hazelhurst S
Biochem Biophys Res Commun; 2020 Jun; 527(3):702-708. PubMed ID: 32410735
[TBL] [Abstract][Full Text] [Related]
36. Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates.
Alazmi M; Motwalli O
J Mol Model; 2020 Nov; 26(12):338. PubMed ID: 33175236
[TBL] [Abstract][Full Text] [Related]
37. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.
Lim H; Baek A; Kim J; Kim MS; Liu J; Nam KY; Yoon J; No KT
Sci Rep; 2020 Oct; 10(1):16862. PubMed ID: 33033344
[TBL] [Abstract][Full Text] [Related]
38. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
[TBL] [Abstract][Full Text] [Related]
39. The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies.
Papageorgiou AC; Mohsin I
Cells; 2020 Oct; 9(11):. PubMed ID: 33105869
[TBL] [Abstract][Full Text] [Related]
40. Mass Spectrometry and Structural Biology Techniques in the Studies on the Coronavirus-Receptor Interaction.
Witkowska D
Molecules; 2020 Sep; 25(18):. PubMed ID: 32927621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
